• 1
    Albert K.A., Helmer-Matyjek E., Nairn A.C., Muller T.H., Haycock J.W., Greene L.A., Goldstein M., Greengard P. (1984) Calcium/phospholipid-dependent protein kinase (protein kinase C) phosphorylates and activates tyrosine hydroxylase.Proc. Natl. Acad. Sci. USA 81,77137717.
  • 2
    Argiolas A., Fadda F., Melis M.R., Gessa G.L. (1979) Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area.Life Sci. 24,22792284.
  • 3
    Argiolas A., Fadda F., Melis M.R., Gessa G.L. (1980) Differential effect of haloperidol on DOPAC levels in the substantia nigra and ventral tegmental area.Pharmacol. Res. Commun. 12,683688.
  • 4
    Argiolas A., Melis M.R., Fadda F., Serra G., Gessa G.L. (1982) Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.J. Neurochem. 38,7579.
  • 5
    Bunney B.S., Walters J.R., Roth R.H., Aghajanian G.K. (1973) Dopaminergic neurons : effect of antipsychotic drugs and amphetamine on single cell activity.J. Pharmacol. Exp. Ther. 185,560571.
  • 6
    Bunney B.S., Skirboll L.R., Grace A.A. (1980) Acute and chronic haloperidol treatment : effects on nigrostriatal dopaminergic system activity.Adv. Biochem. Psychopharmacol. 24,267273.
  • 7
    Cragg S.J. & Greenfield S.A. (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.J. Neurosci. 17,57385746.
  • 8
    Daubner S.C., Lauriano C., Haycock J.W., Fitzpatrick P.F. (1992) Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase : effects of dopamine and cAMP-dependent phosphorylation on enzyme activity.J. Biol. Chem. 267,1263912646.
  • 9
    Funakoshi H., Okuno S., Fujisawa H. (1991) Different effects on activity caused by phosphorylation of tyrosine hydroxylase at serine 40 by three multifunctional protein kinases.J. Biol. Chem. 266,1561415620.
  • 10
    Gale K., Costa E., Toffano G., Hong J., Guidotti A. (1978) Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.J. Pharmacol. Exp. Ther. 206,2937.
  • 11
    Gudelsky G.A. & Meltzer H.Y. (1989) Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychotics.Neuropsychopharmacology 2,4551.
  • 12
    Haavik J., Martinez A., Flatmark T. (1990) pH-dependent release of catecholamines from tyrosine hydroxylase and the effect of phosphorylation at Ser-40.FEBS Lett. 262,363365.
  • 13
    Harada K., Wu J., Haycock J.W., Goldstein M. (1996) Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme.J. Neurochem. 67,629635.
  • 14
    Haycock J.W. (1989) Quantitation of tyrosine hydroxylase protein levels : spot immunolabeling with an affinity purified antibody.Anal. Biochem. 181,259266.
  • 15
    Haycock J.W. (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, 40.J. Biol. Chem. 265,1168211691.
  • 16
    Haycock J.W. (1996) Short- and long-term regulation of tyrosine hydroxylase in chromaffin cells by VIP and PACAP.Ann. NY Acad. Sci. 805,219231.
  • 17
    Haycock J.W. & Haycock D.A. (1991) Tyrosine hydroxylase in rat brain dopaminergic nerve terminals : multiple-site phosphorylation in vivo and in synaptosomes.J. Biol. Chem. 266,56505657.
  • 18
    Haycock J.W., Ahn N.G., Cobb M.H., Krebs E.G. (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ.Proc. Natl. Acad. Sci. USA 89,23652369.
  • 19
    Haycock J.W., Lew J.Y., Garcia-Espana A., Lee K.Y., Harada K., Meller E., Goldstein M. (1998) Role of serine-19 phosphorylation in regulating tyrosine hydroxylase studied with site- and phosphospecific antibodies and site-directed mutagenesis.J. Neurochem. 71,16701675.
  • 20
    Hjorth S. & Carlsson A. (1988) In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.J. Neural Transm. 72,8397.
  • 21
    Hoffman A.F. & Gerhardt G.A. (1999) Differences in pharmacological properties of dopamine release between the substantia nigra and striatum : an in vivo electrochemical study.J. Pharmacol. Exp. Ther. 289,455463.
  • 22
    Iorio L.C., Barnett A., Leitz F.H., Houser V.P., Korduba C.A. (1983) SCH23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.J. Pharmacol. Exp. Ther. 226,462468.
  • 23
    Lew J.Y., Garcia-Espana A., Lee K.Y., Carr K.D., Goldstein M., Haycock J.W., Meller E. (1998) Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.Mol. Pharmacol. 55,202209.
  • 24
    Magnusson O., Mohringe B., Fowler C.J. (1987) Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.J. Neural Transm. 69,163177.
  • 25
    Mitchell J.P., Hardie D.G., Vulliet P.R. (1990) Site-specific phosphorylation of tyrosine hydroxylase after KCl depolarization and nerve growth factor treatment of PC12 cells.J. Biol. Chem. 265,2235822364.
  • 26
    Murrin C. & Roth R.H. (1976) Dopaminergic neurons : effects of electrical stimulation on dopamine biosynthesis.Mol. Pharmacol. 12,463475.
  • 27
    Murrin C., Morgenroth V.H., Roth R.H. (1976) Dopaminergic neurons : effects of electrical stimulation on tyrosine hydroxylase.Mol. Pharmacol. 12,10701081.
  • 28
    Nissbrandt H., Sundström E., Jonsson G., Hjorth S., Carlsson A. (1989) Synthesis and release of dopamine in rat brain : comparison between substantia nigra pars compacta, pars reticulata, and striatum.J. Neurochem. 52,11701182.
  • 29
    Ordway G.A., Smith K.S., Haycock J.W. (1994) Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims.J. Neurochem. 62,680685.
  • 30
    Ramsey A.J. & Fitzpatrick P.F. (1998) Effects of phosphorylation of serine 40 of tyrosine hydroxylase on binding of catecholamines : evidence for a novel regulatory mechanism.Biochemistry 37,89808986.
  • 31
    Roskoski R.J, Vulliet P.R., Glass D.B. (1987) Phosphorylation of tyrosine hydroxylase by cyclic GMP-dependent protein kinase.J. Neurochem. 48,840845.
  • 32
    Salah R.S., Kuhn D.M., Galloway M.P. (1989) Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices.J. Neurochem. 52,15171522.
  • 33
    Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. (1985) Measurement of protein using bicinchoninic acid.Anal. Biochem. 150,7685.
  • 34
    Stoof J.C. & Kebabian J.W. (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.Nature 294,366368.
  • 35
    Strait K.A. & Kuczenski R. (1986) Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.Mol. Pharmacol. 29,561569.
  • 36
    Sutherland C., Alterio J., Campbell D.G., LeBourdelles B., Mallet J., Haavik J., Cohen P. (1993) Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2.Eur. J. Biochem. 217,715722.
  • 37
    Thomas G., Haavik J., Cohen P. (1997) Participation of a stress-activated protein kinase cascade in the activation of tyrosine hydroxylase in chromaffin cells.Eur. J. Biochem. 247,11801189.
  • 38
    Vulliet P.R., Langan T.A., Weiner N. (1980) Tyrosine hydroxylase : a substrate for cyclic AMP-dependent protein kinase.Proc. Natl. Acad. Sci. USA 77,9296.
  • 39
    Vulliet P.R., Woodgett J.R., Cohen P. (1984) Phosphorylation of tyrosine hydroxylase by calmodulin-dependent multiprotein kinase.J. Biol. Chem. 259,1368013683.
  • 40
    Vulliet P.R., Woodgett J.R., Ferrari S., Hardie D.G. (1985) Characterization of the sites phosphorylated on tyrosine hydroxylase by Ca2+ and phospholipid-dependent protein kinase, calmodulin-dependent multiprotein kinase and cyclic AMP-dependent protein kinase.FEBS Lett. 182,335339.
  • 41
    Waymire J.C., Johnston J.P., Hummer-Lickteig K., Lloyd A., Vigny A., Craviso G.L. (1988) Phosphorylation of bovine adrenal chromaffin cell tyrosine hydroxylase : temporal correlation of acetylcholine's effect on site phosphorylation, enzyme activation, and catecholamine synthesis.J. Biol. Chem. 263,1243912447.
  • 42
    Waymire J.C., Craviso G.L., Lichteig K., Johnston J.P., Baldwin C., Zigmond R.E. (1991) Vasoactive intestinal peptide stimulates catecholamine biosynthesis in isolated adrenal chromaffin cells : evidence for a cyclic AMP-dependent phosphorylation and activation of tyrosine hydroxylase.J. Neurochem. 57,13131324.
  • 43
    Westerink B.H.C. & Korf J. (1976) Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.Eur. J. Pharmacol. 40,131136.
  • 44
    Zivkovic B. & Guidotti A. (1974) Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors.Brain Res. 79,505509.
  • 45
    Zivkovic B., Guidotti A., Costa E. (1974) Effects of neuroleptics on striatal tyrosine hydroxylase : changes in affinity for the pteridine cofactor.Mol. Pharmacol. 10,727735.
  • 46
    Zivkovic B., Guidotti A., Costa E. (1975 a) The regulation of striatal tyrosine hydroxylase : effects of gamma hydroxybutyric acid and haloperidol. Naunyn Schmeidebergs Arch. Pharmacol. 291,193200.
  • 47
    Zivkovic B., Guidotti A., Revuelta A., Costa E. (1975 b) Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 194,3746.